How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

2,985 results for

E/M Established Outpatient Visit

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

41. Improving outdoor air quality and health: review of interventions

Bradley, Alec Dobney, Karen Exley, Jim Stewart-Evans Stuart Aldridge, Amanda Craswell, Sani Dimitroulopoulou, Greg Hodgson, Lydia Izon- Cooper, Laura Mitchem, Christina Mitsakou, Sarah Robertson Project manager:Jim Stewart-Evans For queries relating to this document, please contact: AQreview@phe.gov.uk © Crown copyright 2019 You may re-use this information (excluding logos) free of charge in any format or medium, under the terms of the Open Government Licence v3.0. To view this licence, visit OGL (...) of interventions to improve outdoor air quality and public health 10 Improving air quality can go hand in hand with economic growth. A common misconception is that air pollution is a necessary consequence of economic prosperity, whereas a clean environment is increasingly understood to support, rather than hinder, economic growth. People prefer to live, and employers are likely to prefer to establish businesses, in places which are clean and support a healthy workforce. Furthermore, the UK is at the forefront

2019 Public Health England

42. Supporting Rapid Learning and Improvement Across Ontario’s Health System

), and communities of practice appear promising to support problem-focused initiatives. • Element 2 – Support local area-focused rapid learning and improvement o This element could include: building local capacity (within health organizations and with front-line staff) and establishing dedicated staff to identify improvement priorities; determining what resources are available in (and beyond) local organizations and how they can be effectively harnessed to support rapid learning and improvement; and creating (...) of frequent service users; 2) experimentation with funding models (known as ‘bundled care’) to promote greater integration in healthcare delivery, drive high-quality and efficient care, and improve patient experiences and outcomes; and 3) the establishment of the Patients’ Ombudsman to champion fairness in health organizations across the province. In the research system, one step in this direction was the creation and operationalization of the Ontario Strategy on Patient-Oriented Research (SPOR) SUPPORT

2019 McMaster Health Forum

43. Diagnosis and Management of Acute Pulmonary Embolism

Plasminogen Activator for Occluded Coronary Arteries HAS-BLED Hypertension, Abnormal renal/liver function, Stroke, Bleeding history or predisposition, Labile international normalized ratio, Elderly (>65 years), Drugs/alcohol concomitantly HERDOO2 Hyperpigmentation, Edema, or Redness in either leg; D-dimer level ≥250 μg/L; Obesity with body mass index ≥30 kg/m 2 ; or Older age, ≥65 years H-FABP Heart-type fatty acid-binding protein HIV Human immunodeficiency virus HR Hazard ratio INR International (...) normalized ratio IU International units i.v Intravenous IVC Inferior vena cava LA Left atrium LMWH Low-molecular weight heparin(s) LV Left ventricle/ventricular MRA Magnetic resonance angiography NCT National clinical trial NOAC(s) Non-vitamin K antagonist oral anticoagulant(s) NT-proBNP N-terminal pro B-type natriuretic peptide NYHA New York Heart Association OBRI Outpatient Bleeding Risk Index o.d Omni die (once a day) OR Odds ratio PAH Pulmonary arterial hypertension PAP Pulmonary artery pressure PE

Full Text available with Trip Pro

2019 European Society of Cardiology

44. Regional Models of Care for Systemic Treatment: Standards for the Organization and Delivery of Systemic Treatment

For information about this document, please contact Dr. Leta Forbes, the lead author, through the PEBC via: Phone: 905-527-4322 ext. 42822 Fax: 905 526-6775 E-mail: ccopgi@mcmaster.ca For information about the PEBC and the most current version of all reports, please visit the CCO website at http: https://www.cancercareontario.ca/en/guidelines-advice or contact the PEBC office at: Phone: 905-527-4322 ext. 42822 Fax: 905 526-6775 E-mail: ccopgi@mcmaster.ca PEBC Report Citation (Vancouver Style): Forbes L (...) for CPOE and labelling.* For additional information, please see Computerized Prescriber Order Entry (CPOE) in the Outpatient Oncology Setting, Patient Safety Issues: Key Components of Chemotherapy Labelling, Systemic Treatment Computerized Prescriber Order Entry (ST CPOE: Best Practice Guideline for Intravenous and Oral Chemotherapy and Appendix 1 #3-5 . ? Ability to submit e-claims eligibility forms.* ? Potential for videoconference, remote web-based teaching as part of multidisciplinary cancer

2019 Cancer Care Ontario

45. Oncology Nursing Telepractice Standards

Telemedicine Association. (2014). Core operational Guidelines for Telehealth Services Involving Provider-Patient Interactions. Retrieved from http://www.uwyo.edu/wind/_files/docs/wytn-doc/toolkit- docs/ata_core_provider.pdf 26.Lake, R., Georgiou, A., Li, J., Li, L., Byrne, M., Robinson, M., & Westbrook, J. I. (2017). The quality, safety and governance of telephone triage and advice services–an overview of evidence from systematic reviews. BMC Health Services Research, 17(1), 614. 27.Scott, D., Richard, E (...) Oncology Nursing Telepractice Standards Care Ontario Oncology Nursing Telepractice Standards Oncology Nursing Program August, 2019 Oncology Nursing Telepractice Standards 1 INTRODUCTION In 2017, the Oncology Nursing Program at Cancer Care Ontario completed a current state assessment across the province. The goal of the assessment was to gain a better understanding of the current landscape of oncology nursing in the outpatient setting, including nursing roles and models of nursing care delivery

2019 Cancer Care Ontario

46. Management of Cancer Medication-Related Infusion Reactions

the first day of administration. 8 Management of Cancer Medication-Related Infusion Reactions 7 Hypersensitivity reactions (HSRs) are a subset of IRs that occur at doses normally tolerated by patients and are not consistent with a known toxicity of the drug. 2 HSRs can be divided into subtypes as defined by Gell and Coombs, depending on the mechanism of reaction. • Type I reactions are those mediated by immunoglobulin E (IgE) antibodies, and include anaphylaxis, a type of systemic HSR that is severe (...) prophylaxis with extended infusion and/or pre-medications reduce IR rates. Current evidence suggests that pre-medications may reduce IR rates; however, the optimal pre- medication regimen has yet to be established. It may be reasonable to consider pre- medications (e.g. corticosteroids, H1-receptor antagonists ± H2-receptor antagonists) routinely in gynecological patients receiving carboplatin starting from the 7 th cycle, especially in patients at high risk of developing an IR. High risk factors include

2019 Cancer Care Ontario

47. Shared decision making training programs for doctors: A Rapid Review

the use of shared decision making by healthcare professionals. Cochrane Database of Systematic Reviews, (7). 2. Epstein, R. M., Duberstein, P. R., Fenton, J. J., Fiscella, K., Hoerger, M., Tancredi, D. J,& Kaesberg, P. (2017). Effect of a patient-centered communication intervention on oncologist-patient communication, quality of life, and health care utilization in advanced cancer: the VOICE randomized clinical trial. JAMA Oncology, 3(1), 92-100. 3. Gist, D. L., Bhushan, R., Hamarstrom, E., Sluka, P (...) was not set in a particular setting, [8] and the others were set across a range of primary and secondary settings. [9,10] The settings included: oncology; [2,5] psoriasis; [3] general surgery, [6] and a multicenter trial including a stroke unit, multiple sclerosis outpatient ward, stem cell transplantation unit, clinics of dentistry, radiation oncology, surgery, neurosurgery, and three clinics of gynecology. [4] Below is the summary of findings outlined by setting type (Table 2). The two randomised

2019 Monash Health Evidence Reviews

48. Inotuzumab ozogamicin for treating relapsed or refractory B-cell acute lymphoblastic leukaemia

model Administr Administration costs based on INO-V ation costs based on INO-VA ATE TE 1022 and 9.5 1022 and 9.5 inpatient da inpatient days in both arms ys in both arms are preferred are preferred 3.13 The company's model assumed that administering inotuzumab ozogamicin would need 3 outpatient visits and no inpatient days per cycle, compared with Inotuzumab ozogamicin for treating relapsed or refractory B-cell acute lymphoblastic leukaemia (TA541) © NICE 2019. All rights reserved. Subject to Notice (...) of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 14 of 31no outpatient visits and 6.2 inpatient days for standard care (based on the summary of product characteristics). The ERG stated that the company's assumptions underestimated the cost of administering inotuzumab ozogamicin because no inpatient days were included. The clinical expert agreed with the ERG and also highlighted that patients having standard care often need an extended stay in hospital. The ERG's

2018 National Institute for Health and Clinical Excellence - Technology Appraisals

49. Public health service provision by community pharmacies: a systematic map of evidence

: This report should be cited as: Stokes G, Rees R, Khatwa M, Stansfield C, Burchett H, Dickson, K, Brunton G, Thomas J (2019) Public health service provision by community pharmacies: a systematic map of evidence. London: EPPI-Centre, Social Science Research Unit, Institute of Education, University College London. Funding This report is independent research commissioned by the National Institute for Health Research (NIHR) Policy Research Programme (PRP) for the Department of Health and Social Care (DHSC (...) with a global agenda for improving healthy life expectancy through accessible, multi-disciplinary networks of community-based healthcare professionals (World Health Organization 2004; DH 2008). It is estimated there are 11,619 community pharmacies across England. It is estimated that 1.6 million people visit a pharmacy every day and that 1.2 million of these visits are for health-related reasons. (LGA 2013; PSNC 2013a). Community pharmacies are easily accessible to people seeking local healthcare (PHE 2014

2019 EPPI Centre

50. Management of opioid use disorders: a national clinical practice guideline

, prescription opioid, and illicitly made fentanyl overdoses: challenges and innovations responding to a dynamic epidemic. Int J Drug Policy 2017;46:172-9. 2. Canadian Institute for Health Information, Canadian Centre on Substance Abuse. Hospitalizations and emergency department visits due to opioid poison- ing in Canada. Ottawa: Canadian Institute for Health Information; 2016. 3. Bruneau J, Roy E, Arruda N, et al. The rising prevalence of prescription opioid injection and its association with hepatitis C (...) management (without transition to opioid agonist treatment) is pursued, provide supervised slow (> 1 mo) opioid agonist taper (in an outpatient or residential treatment setting) rather than a rapid (< 1 wk) taper. During opioid-assisted withdrawal management, patients should be transitioned to long-term addiction treatment† to help prevent relapse and associated health risks. Moderate Strong 8. For patients with a successful and sustained response to opioid agonist treatment who wish to discontinue

2018 CPG Infobase

51. Deprescribing benzodiazepine receptor agonists

if considering deprescribing Continue AP Good practice recommendation Stop AP Bjerre LM, Farrell B, Hogel M, Graham L, Lemay G, McCarthy L, et al. Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia. Evidence-based clinical practice guideline. Can Fam Physician 2018;64:17-27 (Eng), e1-12 (Fr). deprescribing@bruyere.org or visit deprescribing.org for more information. Figure 1 Algorithme de déprescription des antipsychotiques (AP) Octobre 2016 Suivi toutes les une (...) , McCarthy L, et al. Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia. Evidence-based clinical practice guideline. Can Fam Physician 2018;64:17-27 (Eng), e1-12 (Fr). deprescribing@bruyere.org or visit deprescribing.org for more information. Algorithme de déprescription des antipsychotiques (AP) Octobre 2016 Suivi toutes les une à deux semaines pendant la réduction graduelle Bjerre LM, Farrell B, Hogel M, Graham L, Lemay G, McCarthy L, Raman Wilms L, Rojas

2018 CPG Infobase

52. Pharmacological management of migraine

Abbreviations 34 Annexes 35 References 42 Pharmacological management of migraine Pharmacological management of migraine| 1 1 Introduction 1.1 THE NEED FOR A GUIDELINE Headache is common, with a lifetime prevalence of over 90% of the general population in the United Kingdom (UK). 1 It accounts for 4.4% of consultations in primary care and 30% of neurology outpatient consultations. 1-4 Headache disorders are classified as either primary or secondary. 5 Primary headache disorders are not associated (...) and Therapeutics Committees about the status of all newly-licensed medicines, all new formulations of existing medicines and new indications for established products. NHSScotland should take account of this advice and ensure that medicines accepted for use are made available to meet clinical need where appropriate. SMC advice relevant to this guideline is summarised in section 8.4. Pharmacological management of migraine| 5 2 Key recommendations The following recommendations were highlighted by the guideline

2018 SIGN

53. Diagnosis and management of epilepsy in adults

indications for established products. SMC advice relevant to this guideline is summarised in section 11.4. Diagnosis and management of epilepsy in adults 1 • Introduction 4 | 2 Key recommendations The following recommendations were highlighted by the guideline development group as the key clinical recommendations that should be prioritised for implementation. The grade of recommendation relates to the strength of the supporting evidence on which the recommendation is based. It does not reflect (...) time for the patient and by an appropriate healthcare professional (consultant neurologist, physician with an interest in epilepsy, specialist registrar, or epilepsy nurse specialist). 2.7 MODELS OF CARE D A structured management system for patients with epilepsy should be established in primary care. As with other chronic diseases, an annual review is desirable. Diagnosis and management of epilepsy in adults 2 • Key recommendations6 | 3 Diagnosis 3.1 WHO SHOULD MAKE THE DIAGNOSIS OF EPILEPSY

2018 SIGN

54. Optimisation of RIZIV – INAMI lump sums for incontinence

). For women, pregnancy, delivery and parturition factors e.g. instrumental delivery and birth weight, are risk factors for UI in the post- partum period. Further, body mass has been established as an important risk factor for UI while other modifiable factors include smoking, diet, depression, constipation, urine tract infections, and strenuous exercise (e.g. jumping). Although associated with UI, they are not considered established independent risk factors. In older women, physical function and moderate (...) The management of UI is often a combination of options, including conservative, pharmacological and surgical management [13] . The care pathways are described further below. After an initial assessment (history, physical examination, laboratory tests) establishing a presumptive diagnosis, and excluding underlying organ-specific conditions requiring specialist intervention, as well as assessing the level of bother and desire for intervention from information obtained from the patient or caregivers

2019 Belgian Health Care Knowledge Centre

55. Diagnosis and management of gonorrhoea and syphilis

, Syphilis, Chlamydia trachomatis NLM Classification: WA 110 Prevention and control of communicable diseases. Transmission of infectious diseases Language: English Format: Adobe® PDF™ (A4) Legal depot: D/2019/10.273/21 ISSN: 2466-6459 Copyright: KCE reports are published under a “by/nc/nd” Creative Commons Licence http://kce.fgov.be/content/about-copyrights-for-kce-publications. How to refer to this document? Jespers V, Stordeur S, Desomer A, Carville S, Jones C, Lewis S, Perry M, Cordyn S, Cornelissen T (...) , Crucitti T, Danhier C, De Baetselier I, De Cannière A-S, Dhaeze W, Dufraimont E, Kenyon C, Libois A, Mokrane S, Padalko E, Van den Eynde S, Vanden Berghe W, Van der Schueren T, Dekker N. Diagnosis and management of gonorrhoea and syphilis. Good Clinical Practice (GCP) Brussels: Belgian Health Care Knowledge Centre (KCE). 2019. KCE Reports 310. D/2019/10.273/21. This document is available on the website of the Belgian Health Care Knowledge Centre. KCE Report 310 Diagnosis and management of gonorrhoea

2019 Belgian Health Care Knowledge Centre

56. Bariatric surgery: an HTA report on the efficacy, safety and cost-effectiveness

underwent RYGB at one centre in the US between 2001 and 2007. 86 Of these, 58 (78%) were included in the long-term analysis. At baseline, the mean BMI was 58.5 (±10.5) kg/m². In the first 12 months after gastric bypass, BMI decreased by mean 22.8 (±5.5) kg/m². At mean follow- up of 8.0 years (range 5.4-12.5), the mean BMI was 41.7 (±12.0) kg/m². At the long-term follow-up visit 21 (37%) participants had a BMI 35 kg/m²) individuals. 87 The primary focus in the present paragraph is on the impact (...) Commons Licence http://kce.fgov.be/content/about-copyrights-for-kce-publications. How to refer to this document? Louwagie P, Neyt M, Dossche D, Camberlin C, ten Geuzendam B, Van den Heede K, Van Brabandt H. Bariatric surgery: an HTA report on the efficacy, safety and cost-effectiveness. Health Technology Assessment (HTA) Brussels: Belgian Health Care Knowledge Centre (KCE). 2019. KCE Reports 316. D/2019/10.273/44. This document is available on the website of the Belgian Health Care Knowledge Centre

2019 Belgian Health Care Knowledge Centre

57. Recurrent uncomplicated urinary tract infections in women: AUA/CUA/SUFU

seeking prevention of urinary tract infections (UTIs) in the operative or procedural setting. In this document, the term UTI will refer to acute bacterial cystitis unless otherwise specified. This document seeks to establish guidance for the evaluation and management of patients with rUTIs to prevent inappropriate use of antibiotics, decrease the risk of antibiotic resistance, reduce adverse effects of antibiotic use, provide guidance on antibiotic and non-antibiotic strategies for prevention (...) Typically, for a diagnosis of cystitis, acute-onset symptoms should occur in conjunction with the laboratory detection of a uropathogen from the urine, typically E. coli (75-95%), but occasionally other pathogens such as other Enterobacteriaceae, P. mirabilis, K. pneumoniae, and S. saprophyticus . Other species are rarely isolated in uncomplicated UTI. 20,21 Urine culture remains the mainstay of diagnosis of an episode of acute cystitis; urinalysis provides little increase in diagnostic accuracy. 22

2019 Canadian Urological Association

58. Policy on Medically-Necessary Care

. Lee LJ, Bouwens TJ, Savage MF, Vann WF Jr. Examining the cost-effectiveness of early dental visits. Pediatr Dent 2006;28(2):102-5, discussion 192-8. 44. Ladewig NM, Camargo LB, Tedesco TK, et al. Management of dental caries among children: A look at cost-effectiveness. Expert Rev Pharmacoecon Outcomes Res 2018;18(2):127-34. Available at: “https://www.researchgate.net/publication/ 321651003/download”. Accessed August 10, 2019. 45. Foster T, Perinpanayagam H, Pfaffenbach A, Certo M. Recurrence (...) of early childhood caries after comprehensive treatment with general anesthesia and follow-up. J Dent Child 2006;73(1):25-30. 46. Eidelman E, Faibis S, Peretz B. A comparison of restorations for children with early childhood caries treated under general anesthesia or conscious sedation. Pediatr Dent 2000;22(1):33-7. 47. Almeida AG, Roseman MM, Sheff M, Huntington N, Hughes CV. Future caries susceptibility in children with early childhood caries following treatment under general anesthesia. Pediatr Dent

2019 American Academy of Pediatric Dentistry

59. Tuberculosis

home visits to give information and advice to people who are disadvantaged on the importance of immunisation. This should be delivered by trained lay health workers, community-based healthcare staff or nurses. [new 2016] [new 2016] BCG v BCG vaccination for healthcar accination for healthcare work e workers ers 1.1.3.16 Offer BCG vaccination to healthcare workers and other NHS employees as advised in the Green Book. [2006, amended 2016] [2006, amended 2016] BCG v BCG vaccination for contacts (...) (that is, without adequate documentation or a BCG scar) and and are aged: younger than 16 years or or 16–35 years from sub-Saharan Africa or a country with a TB incidence of 500 per 100,000 or more. [2006, amended 2016] [2006, amended 2016] Tuberculosis (NG33) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 11 of 178Encour Encouraging uptak aging uptake among infants, older childr e among infants, older children and new entr en

2016 National Institute for Health and Clinical Excellence - Clinical Guidelines

60. Women and women with children residential rehabilitation best practice

• Longitudinal research to determine the long-term effect of the different models of care • Models of care that have been established in the US need to be evaluated in the Australian setting. Programs such as the Oxford House design (with women living in a share house to support each other) warrants further investigation • Treatment outcomes for diverse cultural groups need to the evaluated. Specific attention should be given to Indigenous communities, where respect is a cultural requirement to ensure client (...) 4 observed the ratio of men and women in rehabilitation is less than the gender prevalence of substance use in the community. Also, women with substance abuse disorders tend to experience more severe medical and social consequences when compared to men. She noted that the odds of completing treatment were three times higher among adult clients in non-hospital residential rehabilitation facilities when compared to those in outpatient methadone programs. These findings suggest that more needs

2018 Sax Institute Evidence Check

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>